Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 12 trials

Late-Stage Pipeline

33%

4 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
5(41.7%)
Phase 3
4(33.3%)
Phase 1
2(16.7%)
Phase 2
1(8.3%)
12Total
N/A(5)
Phase 3(4)
Phase 1(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)

Showing 12 of 12 trials
NCT07028801Phase 3Not Yet Recruiting

Clinical Trial of Freeze-dried Human Rabies Vaccine (Human Diploid Cells)

Role: lead

NCT07021703Phase 1Recruiting

A Clinical Trial of Rabies Vaccine(Human Diploid Cell)for Human Use,Freeze-dried

Role: lead

NCT05939648Phase 2Unknown

A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021)

Role: collaborator

NCT05969626Phase 3Unknown

Clinical Trial of Freeze-dried Human Rabies Vaccine (Without Serum Vero Cells)

Role: lead

NCT05812014Phase 3Unknown

Clinical Trail of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021) in Participants Aged 18 Years and Older

Role: collaborator

NCT05549206Not ApplicableUnknown

A Cohort Study of SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine in Participants Aged 18 Years and Over in Chinese People

Role: collaborator

NCT05745545Not ApplicableUnknown

Clinical Trial of COVID-19 Vaccine(SARS-CoV-2 Variant(Omicron BA.5) mRNA Vaccine) in Participants Aged 18 Years and Over

Role: collaborator

NCT05682638Phase 3Unknown

A Global Multi-center Clinical Study of SARS-CoV-2 mRNA Vaccine for the Prevention of COVID-19

Role: collaborator

NCT05547243Not ApplicableUnknown

A Cohort Study of COVID-19 mRNA Vaccine, Bivalent in Participants in China

Role: collaborator

NCT05547256Not ApplicableUnknown

A Preliminary Exploratory Cohort Study of COVID-19 mRNA Vaccine, Bivalent in Participants Aged 18 Years and Over in China

Role: collaborator

NCT05550142Not ApplicableUnknown

A Preliminary Exploratory Cohort Study of SARS-CoV-2 Variant (Omicron BA.5) mRNA Vaccine in Participants Aged 18 Years and Over in China

Role: collaborator

NCT05599802Phase 1Unknown

Clinical Study of SARS-CoV-2 Variant mRNA Vaccine in Healthy Participants

Role: collaborator

All 12 trials loaded